255 related articles for article (PubMed ID: 33662359)
21. [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.].
Tretyakova YI; Bulatova IA; Shchekotova AP; Sheludko VS
Klin Lab Diagn; 2018; 63(7):414-418. PubMed ID: 30720956
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Serum Total Bilirubin in Predicting the Severity of Ulcerative Colitis: A Cross-Sectional Study.
Zhang MH; Wang HG; Shi YT; Zhou JF; Yan W; Ma TH; Wu SN; Yang XZ
Ann Clin Lab Sci; 2020 Mar; 50(2):228-232. PubMed ID: 32366561
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
Xiang JY; Ouyang Q; Li GD; Xiao NP
World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
[TBL] [Abstract][Full Text] [Related]
24. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
25. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis.
Motooka K; Morishita K; Ito N; Shinzaki S; Tashiro T; Nojima S; Shimizu K; Date M; Sakata N; Yamada M; Takamatsu S; Kamada Y; Iijima H; Mizushima T; Morii E; Takehara T; Miyoshi E
World J Gastroenterol; 2021 Jan; 27(2):162-175. PubMed ID: 33510557
[TBL] [Abstract][Full Text] [Related]
26. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score.
Jairath V; Jeyarajah J; Zou G; Parker CE; Olson A; Khanna R; D'Haens GR; Sandborn WJ; Feagan BG
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):63-70. PubMed ID: 30343116
[TBL] [Abstract][Full Text] [Related]
27. What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
Shin J; Kong SM; Seong G; Kim YH
Int J Colorectal Dis; 2020 Dec; 35(12):2249-2255. PubMed ID: 32749515
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein/albumin ratio and IL-6 are associated with disease activity in patients with ulcerative colitis.
Feng W; Zhu L; Liu Y; Xu L; Shen H
J Clin Lab Anal; 2023 Feb; 37(3):e24843. PubMed ID: 36725336
[TBL] [Abstract][Full Text] [Related]
29. A cutoff value for the Systemic Immune-Inflammation Index in determining activity of Behçet disease.
Tanacan E; Dincer D; Erdogan FG; Gurler A
Clin Exp Dermatol; 2021 Mar; 46(2):286-291. PubMed ID: 32869876
[TBL] [Abstract][Full Text] [Related]
30. [Improved Mayo Endoscopic Score has a higher value for evaluating clinical severity of ulcerative colitis].
Song Z; Zhang M; Ren Y; Iang B
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):997-1005. PubMed ID: 35869761
[TBL] [Abstract][Full Text] [Related]
31. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
32. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.
Bewtra M; Brensinger CM; Tomov VT; Hoang TB; Sokach CE; Siegel CA; Lewis JD
Inflamm Bowel Dis; 2014 Jun; 20(6):1070-8. PubMed ID: 24810138
[TBL] [Abstract][Full Text] [Related]
33. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.
Nakov R; Velikova T; Nakov V; Gerova V; Tankova L
J Gastrointestin Liver Dis; 2019 Jun; 28():169-174. PubMed ID: 31204414
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis.
Turner D; Mack DR; Hyams J; LeLeiko N; Otley A; Markowitz J; Kasirer Y; Muise A; Seow CH; Silverberg MS; Crandall W; Griffiths AM
J Crohns Colitis; 2011 Oct; 5(5):423-9. PubMed ID: 21939916
[TBL] [Abstract][Full Text] [Related]
35. Association with controlling nutritional status score and disease activity of ulcerative colitis.
Lian Z; Hu J; Cheng C; Liu Y; Zhu L; Shen H
J Int Med Res; 2023 Aug; 51(8):3000605231184046. PubMed ID: 37548189
[TBL] [Abstract][Full Text] [Related]
36. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT
Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506
[TBL] [Abstract][Full Text] [Related]
37. How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.
Bálint A; Farkas K; Szepes Z; Nagy F; Szűcs M; Tiszlavicz L; Bor R; Milassin Á; Rutka M; Fábián A; Molnár T
BMC Gastroenterol; 2018 Jan; 18(1):7. PubMed ID: 29310593
[TBL] [Abstract][Full Text] [Related]
38. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
39. PLR and IL-8 were Potential Markers in Differential Diagnosis and Disease Activity in Ulcerative Colitis Patients.
He Z; Liu Y; Liu JJ; Shu GF
Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125159
[TBL] [Abstract][Full Text] [Related]
40. CT Enterography score: a potential predictor for severity assessment of active ulcerative colitis.
Jia Y; Li C; Yang X; Dong Z; Huang K; Luo Y; Li X; Sun C; Feng ST; Li ZP
BMC Gastroenterol; 2018 Nov; 18(1):173. PubMed ID: 30413186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
